Kim Monkhorst

After my training at Erasmus MC in Rotterdam, I have been working as a clinical pathologist at the Netherlands Cancer Institute since 2014. In 2008 I obtained my PhD in the context of the mechanism of action of X-chromosome inactivation at the department of cell biology at Erasmus MC and MIT in Boston.

Pathology is a field of study that tries to obtain as much relevant information (biomarkers) as possible from the tumor tissue using various techniques. These biomarkers play an important role in deciding what the most optimal treatment is for a patient. In addition to my diagnostic work, my mission is on the one hand to develop new biomarkers in close collaboration with the Netherlands Cancer Institute and on the other hand to implement newly found biomarkers so that we can use them for the patients of the Netherlands Cancer Institute.

In addition to the focus areas of thoracic oncology and molecular diagnostics, I am chairman of the molecular tumor board. Here, but also in the thoracic oncology tumor working group, I enjoy working with multiple specialists so that we can offer the best possible treatment at the NKI.